Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Veterinary medicines containing diethanolamine suspended
The Veterinary Medicines Directorate (VMD) has suspended veterinary medicines containing diethanolamine.

VMD states excipient may pose a risk to humans

The Veterinary Medicines Directorate (VMD) has suspended veterinary medicines containing diethanolamine (DEA) over concerns the excipient may pose a risk to humans.

In a press release, the VMD said it had made the decision 'in light of scientific opinion of the Committee for Medicinal Products for Veterinary Use (CVMP)'. It states there may be a risk to humans from consuming food from animals treated with products containing DEA.

The affected products are as follows:

Product VM Number MAH
Allevinix 50 mg/ml Solution for Injection for Cattle, Pigs and Horses 15052/4144 Ceva Animal Health Ltd
Cronyxin Injection, 5% w/v Solution for Injection
 
12597/4014 Cross Vetpharm Group Ltd
Dugnixon 50 mg/ml Solution for Injection for Cattle, Pigs and Horses 36167/4005 Global Vet Health S.L.
Finadyne 50 mg/ml Solution for Injection  01708/4582 Intervet UK Ltd
Flunixin 50 mg/ml Solution for Injection for Cattle, Horses and Pigs 02000/4170 Norbrook Laboratories Limited
Meflosyl 5% Solution for Injection 42058/4085 Zoetis UK Limited
Norixin 5% Solution for Injection 02000/4137 Norbrook Laboratories Limited
Pyroflam 50 mg/ml Solution for Injection for Cattle, Horses and Pigs 02000/4253
 
Norbrook Laboratories Limited
Tribrissen 48% Suspension for Injection 01708/4593 Intervet UK Ltd

 

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.